コンテンツへスキップ
Merck
  • Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function.

Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function.

Blood (2021-01-30)
Jahnavi Aluri, Alicia Bach, Saara Kaviany, Luana Chiquetto Paracatu, Maleewan Kitcharoensakkul, Magdalena A Walkiewicz, Christopher D Putnam, Marwan Shinawi, Nermina Saucier, Elise M Rizzi, Michael T Harmon, Molly P Keppel, Michelle Ritter, Morgan Similuk, Elaine Kulm, Michael Joyce, Adriana A de Jesus, Raphaela Goldbach-Mansky, Yi-Shan Lee, Marina Cella, Peggy L Kendall, Mary C Dinauer, Jeffrey J Bednarski, Christina Bemrich-Stolz, Scott W Canna, Shirley M Abraham, Matthew M Demczko, Jonathan Powell, Stacie M Jones, Amy M Scurlock, Suk See De Ravin, Jack J Bleesing, James A Connelly, V Koneti Rao, Laura G Schuettpelz, Megan A Cooper
要旨

Inborn errors of immunity (IEI) are a genetically heterogeneous group of disorders with a broad clinical spectrum. Identification of molecular and functional bases of these disorders is important for diagnosis, treatment, and an understanding of the human immune response. We identified 6 unrelated males with neutropenia, infections, lymphoproliferation, humoral immune defects, and in some cases bone marrow failure associated with 3 different variants in the X-linked gene TLR8, encoding the endosomal Toll-like receptor 8 (TLR8). Interestingly, 5 patients had somatic variants in TLR8 with <30% mosaicism, suggesting a dominant mechanism responsible for the clinical phenotype. Mosaicism was also detected in skin-derived fibroblasts in 3 patients, demonstrating that mutations were not limited to the hematopoietic compartment. All patients had refractory chronic neutropenia, and 3 patients underwent allogeneic hematopoietic cell transplantation. All variants conferred gain of function to TLR8 protein, and immune phenotyping demonstrated a proinflammatory phenotype with activated T cells and elevated serum cytokines associated with impaired B-cell maturation. Differentiation of myeloid cells from patient-derived induced pluripotent stem cells demonstrated increased responsiveness to TLR8. Together, these findings demonstrate that gain-of-function variants in TLR8 lead to a novel childhood-onset IEI with lymphoproliferation, neutropenia, infectious susceptibility, B- and T-cell defects, and in some cases, bone marrow failure. Somatic mosaicism is a prominent molecular mechanism of this new disease.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
CL264, ≥98% (HPLC)
Sigma-Aldrich
TL8-506, ≥98% (HPLC)